<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03136822</url>
  </required_header>
  <id_info>
    <org_study_id>DERMAN</org_study_id>
    <nct_id>NCT03136822</nct_id>
  </id_info>
  <brief_title>DERMALIX Efficacy on Diabetic Foot Ulcers</brief_title>
  <acronym>DERMAN</acronym>
  <official_title>Clinical Evaluation of the Wound Dressing Impregnated With Microparticules (DERMALIX) on Diabetic Foot Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dermis Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dermis Pharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      (DERMALIX) (Patent number: PCT/TR2014/000251) is a bioactive wound dressing that was
      developed by Ege University School of Pharmacy Department of Pharmaceutical Technology. This
      dressing has been categorised as Class III medical device. This clinical study will be
      conducted in patients with diabetic foot ulcers.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 26, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 2, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Open label, controlled, randomised, parallel arm study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The wound will be assessed by Pathologists who are masked for treatment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Recovery of the wound 100%</measure>
    <time_frame>1 month</time_frame>
    <description>The wound will be completely recovered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery of the wound 80%</measure>
    <time_frame>1 month</time_frame>
    <description>The wound will be recovered by 80%</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Diabetic Foot</condition>
  <condition>Diabetic Foot Ulcer</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard dressing + Wound dressing (DERMALIX)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Dressing</intervention_name>
    <description>Standard dressing is applied for treatment of diabetic foot ulcers</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DERMALIX</intervention_name>
    <description>DERMALIX, a class III Medical Device will be applied in addition to standard dressing</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 or 2 Patients diagnosed with diabetic foot ulcers

          -  Class I and II according to Wagner classification

          -  No infections confirmed with culture test

          -  No osteomyelitis and gangrene in the foot

          -  HbA1c values â‰¤ % 7.5

          -  Not active smoker

          -  No planned treatment of hyperbaric oxygen

          -  Patients who give consent for the study

        Exclusion Criteria:

          -  Patients with diabetic foot ulcer of class 3,4 and 5 according to Wagner
             classification

          -  Patients who are pregnant or breast-feeding or female who are in reproductive age
             applying no preservative method

          -  Patients who have mental conditions that lead to difficulties in comprehension

          -  Patients who may have compliance issues

          -  Patients who have been included to another interventional study with drug or medical
             device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sevki Cetinkalp, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ege University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ege University School of Medicine</name>
      <address>
        <city>Izmir</city>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2017</study_first_submitted>
  <study_first_submitted_qc>April 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2017</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetic Foot</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

